$8.46
0[0.00%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$8.48
0.0200[0.24%]
| Open- | Close- |
| Vol / Avg.0 / 3.664M | Mkt Cap2.120B |
| Day Range- - - | 52 Wk Range4.975 - 14.550 |
Pacific Biosciences Stock (NASDAQ:PACB), Key Statistics
Pacific Biosciences Stock (NASDAQ: PACB) analysis, key statistics.
Valuation Measures
Enterprise Value
2.2B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.66
Price / Book (mrq)
3.3
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-16.08%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.56
Tangible Book value per share
-0.71
Total Liabilities (Quarterly)
1.2B
Total Assets
1.8B
Total Liabilities
1.2B
Profitability
Net income Growth
- -
Gross Margin
32.68%
Net Margin
-146.79%
EBIT Margin
-139.65%
EBITDA Margin
-129.42%
Operating Margin
-149.66%
Pacific Biosciences Stock (NASDAQ:PACB), Key Statistics
Pacific Biosciences Stock (NASDAQ: PACB) analysis, key statistics.
Valuation Measures
Enterprise Value
2.2B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.66
Price / Book (mrq)
3.3
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-16.08%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.56
Tangible Book value per share
-0.71
Total Liabilities (Quarterly)
1.2B
Total Assets
1.8B
Total Liabilities
1.2B
Profitability
Net income Growth
- -
Gross Margin
32.68%
Net Margin
-146.79%
EBIT Margin
-139.65%
EBITDA Margin
-129.42%
Operating Margin
-149.66%
Pacific Biosciences Stock (NASDAQ:PACB), Key Statistics
Pacific Biosciences Stock (NASDAQ: PACB) analysis, key statistics.
Valuation Measures
Enterprise Value
2.2B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.66
Price / Book (mrq)
3.3
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-16.08%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.56
Tangible Book value per share
-0.71
Total Liabilities (Quarterly)
1.2B
Total Assets
1.8B
Total Liabilities
1.2B
Profitability
Net income Growth
- -
Gross Margin
32.68%
Net Margin
-146.79%
EBIT Margin
-139.65%
EBITDA Margin
-129.42%
Operating Margin
-149.66%
Pacific Biosciences Stock (NASDAQ:PACB), Key Statistics
Pacific Biosciences Stock (NASDAQ: PACB) analysis, key statistics.
Valuation Measures
Enterprise Value
2.2B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.66
Price / Book (mrq)
3.3
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-16.08%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.56
Tangible Book value per share
-0.71
Total Liabilities (Quarterly)
1.2B
Total Assets
1.8B
Total Liabilities
1.2B
Profitability
Net income Growth
- -
Gross Margin
32.68%
Net Margin
-146.79%
EBIT Margin
-139.65%
EBITDA Margin
-129.42%
Operating Margin
-149.66%
Pacific Biosciences Stock (NASDAQ:PACB), Key Statistics
Pacific Biosciences Stock (NASDAQ: PACB) analysis, key statistics.
Valuation Measures
Enterprise Value
2.2B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.66
Price / Book (mrq)
3.3
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-16.08%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.56
Tangible Book value per share
-0.71
Total Liabilities (Quarterly)
1.2B
Total Assets
1.8B
Total Liabilities
1.2B
Profitability
Net income Growth
- -
Gross Margin
32.68%
Net Margin
-146.79%
EBIT Margin
-139.65%
EBITDA Margin
-129.42%
Operating Margin
-149.66%
Pacific Biosciences Stock (NASDAQ:PACB), Key Statistics
Pacific Biosciences Stock (NASDAQ: PACB) analysis, key statistics.
Valuation Measures
Enterprise Value
2.2B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.66
Price / Book (mrq)
3.3
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-16.08%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.56
Tangible Book value per share
-0.71
Total Liabilities (Quarterly)
1.2B
Total Assets
1.8B
Total Liabilities
1.2B
Profitability
Net income Growth
- -
Gross Margin
32.68%
Net Margin
-146.79%
EBIT Margin
-139.65%
EBITDA Margin
-129.42%
Operating Margin
-149.66%
Pacific Biosciences Stock (NASDAQ:PACB), Key Statistics
Pacific Biosciences Stock (NASDAQ: PACB) analysis, key statistics.
Valuation Measures
Enterprise Value
2.2B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.66
Price / Book (mrq)
3.3
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-16.08%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.56
Tangible Book value per share
-0.71
Total Liabilities (Quarterly)
1.2B
Total Assets
1.8B
Total Liabilities
1.2B
Profitability
Net income Growth
- -
Gross Margin
32.68%
Net Margin
-146.79%
EBIT Margin
-139.65%
EBITDA Margin
-129.42%
Operating Margin
-149.66%
Pacific Biosciences Stock (NASDAQ:PACB), Key Statistics
Pacific Biosciences Stock (NASDAQ: PACB) analysis, key statistics.
Valuation Measures
Enterprise Value
2.2B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.66
Price / Book (mrq)
3.3
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-16.08%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.56
Tangible Book value per share
-0.71
Total Liabilities (Quarterly)
1.2B
Total Assets
1.8B
Total Liabilities
1.2B
Profitability
Net income Growth
- -
Gross Margin
32.68%
Net Margin
-146.79%
EBIT Margin
-139.65%
EBITDA Margin
-129.42%
Operating Margin
-149.66%
Pacific Biosciences Stock (NASDAQ:PACB), Key Statistics
Pacific Biosciences Stock (NASDAQ: PACB) analysis, key statistics.
Valuation Measures
Enterprise Value
2.2B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
13.66
Price / Book (mrq)
3.3
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-16.08%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.56
Tangible Book value per share
-0.71
Total Liabilities (Quarterly)
1.2B
Total Assets
1.8B
Total Liabilities
1.2B
Profitability
Net income Growth
- -
Gross Margin
32.68%
Net Margin
-146.79%
EBIT Margin
-139.65%
EBITDA Margin
-129.42%
Operating Margin
-149.66%